Literature DB >> 28748449

First report of persistent dengue-1-associated autoimmune neurological disturbance: neuromyelitis optica spectrum disorder.

Marzia Puccioni-Sohler1,2,3, Alice M M Ornelas4, Andrea S de Souza5, Mauro Jorge Cabral-Castro4, Jessyca T M A Ramos6, Carolina Rosadas4, Maria Cecilia F Salgado6, Alexandre A Castiglione7, Fernando Ferry6, Jose Mauro Peralta4, Carolina Moreira Voloch4, Amilcar Tanuri4, Fernanda Tovar-Moll4,5, Renato Santana Aguiar4.   

Abstract

Dengue virus (DENV) causes immune-mediated diseases. Neurological involvement represents a severe condition that is rarely observed in DENV-1 infection. Neuromyelitis optica (NMO)/NMO spectrum disorders (NMOSD) are idiopathic immune-mediated demyelinating syndromes of the central nervous system. We report a 17-year-old female with oligosymptomatic DENV-1 viremia, diagnosed as NMOSD. Magnetic resonance imaging showed spinal cord and brainstem lesions. Antibody for aquaporin 4 was negative. DENV-1 RNA infection was detected by serial RT-PCR and confirmed by phylogenetic analysis in serum. Although there are some reports of NMO post-dengue infection, there are not any published accounts of NMOSD with coexistent and persistent DENV-1 infection.

Entities:  

Keywords:  Cerebrospinal fluid; Dengue virus; Magnetic resonance imaging; Neuromyelitis optica spectrum disorder

Mesh:

Year:  2017        PMID: 28748449     DOI: 10.1007/s13365-017-0555-7

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  12 in total

1.  Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction.

Authors:  R S Lanciotti; C H Calisher; D J Gubler; G J Chang; A V Vorndam
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

2.  Neuromyelitis optica spectrum disorder and varicella-zoster infection.

Authors:  Célia Machado; José Amorim; Jaime Rocha; João Pereira; Esmeralda Lourenço; João Pinho
Journal:  J Neurol Sci       Date:  2015-10-04       Impact factor: 3.181

3.  Preferential gray matter involvement in dengue myelitis.

Authors:  M Kunishige; T Mitsui; B H Tan; H N Leong; T Takasaki; I Kurane; A Mihara; T Matsumoto
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

4.  Neurologic dengue manifestations associated with intrathecal specific immune response.

Authors:  M Puccioni-Sohler; C N Soares; R Papaiz-Alvarenga; M J C Castro; L C Faria; J M Peralta
Journal:  Neurology       Date:  2009-10-27       Impact factor: 9.910

5.  Post-dengue neuromyelitis optica: case report of a Japanese-descendent Brazilian child.

Authors:  Adriano Miranda de Sousa; Marzia Puccioni-Sohler; Adalto Dias Borges; Lhano Fernandes Adorno; Marcos Papais Alvarenga; Regina Maria Papais Alvarenga
Journal:  J Infect Chemother       Date:  2007-01-18       Impact factor: 2.211

Review 6.  The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes.

Authors:  Johann Sellner; Bernhard Hemmer; Mark Mühlau
Journal:  J Autoimmun       Date:  2009-10-22       Impact factor: 7.094

7.  Neuromyelitis optica following CMV primo-infection.

Authors:  C Tran; R A Du Pasquier; M Cavassini; Y Guex-Crosier; R Meuli; D Ciuffreda; G Waeber
Journal:  J Intern Med       Date:  2007-05       Impact factor: 8.989

Review 8.  Neurological complications of dengue virus infection.

Authors:  Francisco Javier Carod-Artal; Ole Wichmann; Jeremy Farrar; Joaquim Gascón
Journal:  Lancet Neurol       Date:  2013-09       Impact factor: 44.182

9.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

Review 10.  Protective and Pathological Immunity during Central Nervous System Infections.

Authors:  Robyn S Klein; Christopher A Hunter
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

View more
  2 in total

1.  Neopterin and CXCL-10 in Cerebrospinal Fluid as Potential Biomarkers of Neuroinvasive Dengue and Chikungunya.

Authors:  Marzia Puccioni-Sohler; Samya J da Silva; Luiz C S Faria; David C B I Cabral; Mauro J Cabral-Castro
Journal:  Pathogens       Date:  2021-12-15

2.  Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19.

Authors:  Marzia Puccioni-Sohler; André Rodrigues Poton; Milena Franklin; Samya Jezine da Silva; Rodrigo Brindeiro; Amilcar Tanuri
Journal:  Rev Soc Bras Med Trop       Date:  2020-10-05       Impact factor: 1.581

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.